Physician

Alok Silodia, M.D.

According to 2025 Medicare claims, Alok Silodia, M.D. (NPI: 1023202470) practices nephrology in the Kokomo, IN market, with the plurality of this provider's patient population coming from Howard, IN. This provider's primary affiliated billing organization is INDIANA NEPHROLOGY AND INTERNAL MEDICINE, P.C. (NPI: 1669493722; TIN: 35-1679014) and primary practice location at 46902-6419. Silodia is affiliated with the CHSPSC ACO 2, LLC (ACO ID: A3664), Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403), and Main Street Rural Health Cedar ACO LLC (ACO ID: A5502), participating under the MSSP model.

Silodia's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 318 traditional Medicare patients, billed 1,507 HCPCS/CPT codes, and received $173,753 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 3,220 prescription claims across 443 beneficiaries totaling $469,235 in drug costs, led by Farxiga (Dapagliflozin Propanediol). 2017 DME data shows 15 claims. Open Payments data shows 7 records totaling $124. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $72,880 to $173,753. Similarly, Part D prescription costs have moved sharply higher in recent years, from $11,577 to $469,235. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	388	964	$72,880
2016	153	446	$30,753
2017	N/R	N/R	N/R
2018	88	290	$32,945
2019	338	1,404	$130,060
2020	280	1,190	$96,927
2021	396	1,336	$173,177
2022	425	1,768	$240,218
2023	358	1,425	$217,056
2024	318	1,507	$173,753

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	33	82	$11,577
2016	30	82	$4,099
2017	22	119	$4,590
2018	26	76	$2,123
2019	80	228	$15,545
2020	96	385	$24,150
2021	170	642	$83,635
2022	305	1,625	$199,374
2023	424	2,614	$363,763
2024	443	3,220	$469,235

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	56	$4,816
2016	N/R	44	$2,305
2017	N/R	15	$493
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	70	78	$126
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	86	219	$86
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	60	102	$75
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	130	207	$62
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	150	218	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	184	8,179	$151,773
Lokelma	Sodium Zirconium Cyclosilicate	145	5,169	$80,094
Velphoro	Sucroferric Oxyhydroxide	23	1,050	$67,418
Lanthanum Carbonate	Lanthanum Carbonate	17	630	$16,812
Sevelamer Carbonate	Sevelamer Carbonate	125	6,539	$14,568

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$124	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alok Silodia, M.D.?

Tedicare shows public-source Medicare data for Alok Silodia, M.D. (NPI 1023202470), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alok Silodia, M.D. have ACO affiliation data?

Alok Silodia, M.D. is shown with ACO affiliation data for CHSPSC ACO 2, LLC (MSSP, ACO ID A3664), Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403), and Main Street Rural Health Cedar ACO LLC (MSSP, ACO ID A5502).

What billing organization is linked to Alok Silodia, M.D.?

Alok Silodia, M.D. is linked to INDIANA NEPHROLOGY AND INTERNAL MEDICINE, P.C. (billing NPI 1669493722) in the available physician profile data.

Does Alok Silodia, M.D. have Open Payments data?

Alok Silodia, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.